371 related articles for article (PubMed ID: 30017901)
41. Testosterone therapy of men with type 2 diabetes mellitus - a randomized, double-blinded, placebo-controlled study.
Magnussen LV
Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673384
[TBL] [Abstract][Full Text] [Related]
42. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
43. Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry.
Blick G; Khera M; Bhattacharya RK; Kushner H; Miner MM
Postgrad Med; 2013 Mar; 125(2):19-29. PubMed ID: 23816768
[TBL] [Abstract][Full Text] [Related]
44. 12-month observation of testosterone replacement effectiveness in a general population of men.
Miner MM; Bhattacharya RK; Blick G; Kushner H; Khera M
Postgrad Med; 2013 Mar; 125(2):8-18. PubMed ID: 23816767
[TBL] [Abstract][Full Text] [Related]
45. Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters.
Yassin A; Nettleship JE; Talib RA; Almehmadi Y; Doros G
Aging Male; 2016; 19(1):64-9. PubMed ID: 26742589
[TBL] [Abstract][Full Text] [Related]
46. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.
Debruyne FM; Behre HM; Roehrborn CG; Maggi M; Wu FC; Schröder FH; Jones TH; Porst H; Hackett G; Wheaton OA; Martin-Morales A; Meuleman E; Cunningham GR; Divan HA; Rosen RC;
BJU Int; 2017 Feb; 119(2):216-224. PubMed ID: 27409523
[TBL] [Abstract][Full Text] [Related]
47. Oral testosterone therapy: past, present, and future.
Miller JA; Nguyen TT; Loeb C; Khera M; Yafi FA
Sex Med Rev; 2023 Apr; 11(2):124-138. PubMed ID: 36779549
[TBL] [Abstract][Full Text] [Related]
48. Re: Systematic Review of the Impact of Testosterone Replacement Therapy on Depression in Patients with Late-Onset Testosterone Deficiency.
Griebling TL
J Urol; 2020 Dec; 204(6):1359. PubMed ID: 32960697
[No Abstract] [Full Text] [Related]
49. EMAS position statement: Testosterone replacement therapy in the aging male.
Dimopoulou C; Ceausu I; Depypere H; Lambrinoudaki I; Mueck A; Pérez-López FR; Rees M; van der Schouw YT; Senturk LM; Simonsini T; Stevenson JC; Stute P; Goulis DG
Maturitas; 2016 Feb; 84():94-9. PubMed ID: 26614257
[TBL] [Abstract][Full Text] [Related]
50. Muscular responses to testosterone replacement vary by administration route: a systematic review and meta-analysis.
Skinner JW; Otzel DM; Bowser A; Nargi D; Agarwal S; Peterson MD; Zou B; Borst SE; Yarrow JF
J Cachexia Sarcopenia Muscle; 2018 Jun; 9(3):465-481. PubMed ID: 29542875
[TBL] [Abstract][Full Text] [Related]
51. Long-term testosterone therapy in type 2 diabetes is associated with reduced mortality without improvement in conventional cardiovascular risk factors.
Hackett G; Cole N; Mulay A; Strange RC; Ramachandran S
BJU Int; 2019 Mar; 123(3):519-529. PubMed ID: 30216622
[TBL] [Abstract][Full Text] [Related]
52. Patient-reported outcomes and biochemical alterations during hormonal therapy in men with hypogonadotropic hypogonadism who have finished infertility treatment.
Shiraishi K; Ohmi C; Matsuyama H
Endocr J; 2021 Feb; 68(2):221-229. PubMed ID: 33012744
[TBL] [Abstract][Full Text] [Related]
53. A Pilot Study Using a Web Survey to Identify Characteristics That Influence Hypogonadal Men to Initiate Testosterone Replacement Therapy.
Rosen RC; Seftel AD; Ruff DD; Muram D
Am J Mens Health; 2018 May; 12(3):567-574. PubMed ID: 26819183
[TBL] [Abstract][Full Text] [Related]
54. Testosterone therapy in hypogonadal men: a systematic review and network meta-analysis.
Elliott J; Kelly SE; Millar AC; Peterson J; Chen L; Johnston A; Kotb A; Skidmore B; Bai Z; Mamdani M; Wells GA
BMJ Open; 2017 Nov; 7(11):e015284. PubMed ID: 29150464
[TBL] [Abstract][Full Text] [Related]
55. Update on Testosterone Replacement Therapy in Hypogonadal Men.
Leung KM; Alrabeeah K; Carrier S
Curr Urol Rep; 2015 Aug; 16(8):57. PubMed ID: 26077352
[TBL] [Abstract][Full Text] [Related]
56. Testosterone replacement therapy among HIV-infected men in the CFAR Network of Integrated Clinical Systems.
Bhatia R; Murphy AB; Raper JL; Chamie G; Kitahata MM; Drozd DR; Mayer K; Napravnik S; Moore R; Achenbach C;
AIDS; 2015 Jan; 29(1):77-81. PubMed ID: 25387318
[TBL] [Abstract][Full Text] [Related]
57. Testosterone replacement therapy in men with prostate cancer: a time-varying analysis.
Kaplan AL; Lenis AT; Shah A; Rajfer J; Hu JC
J Sex Med; 2015 Feb; 12(2):374-80. PubMed ID: 25496237
[TBL] [Abstract][Full Text] [Related]
58. Testosterone prescribing in men with depression and anxiety disorders.
Javed Z; Kuo YF; Temple JR; Urban RJ; Holmes H; Baillargeon J
Ann Epidemiol; 2020 Oct; 50():15-19.e8. PubMed ID: 32800673
[TBL] [Abstract][Full Text] [Related]
59. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy.
Sarosdy MF
Cancer; 2007 Feb; 109(3):536-41. PubMed ID: 17183557
[TBL] [Abstract][Full Text] [Related]
60. Assessment of possible effects for testosterone replacement therapy in men with symptomatic late-onset hypogonadism.
Yamaguchi K; Ishikawa T; Chiba K; Fujisawa M
Andrologia; 2011 Feb; 43(1):52-6. PubMed ID: 21219383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
